Forecast: Import of Blood, Antisera, Vaccines, Toxins and Cultures to Japan

In 2023, Japan's imports of blood, antisera, vaccines, toxins, and cultures stood at an actual value of approximately 10.7 billion US dollars. The forecast from 2024 to 2028 shows a steady increase, peaking at 12.757 billion US dollars in 2028. Year-on-year variations for 2024 to 2025 are 3.77%, 2025 to 2026 are 3.56%, 2026 to 2027 are 3.38%, and 2027 to 2028 are 3.19%. The compound annual growth rate (CAGR) over the five-year period is approximately 3.51%.

Future trends to watch for include:

• The potential impact of technological advancements in biotechnology and their influence on import demands.
• Regulatory changes and health policy shifts that may affect the import landscape.
• Economic factors, such as exchange rate fluctuations, that might alter import costs.